Novel inhibitors to Taenia solium Cu/Zn superoxide dismutase identified by virtual screening
暂无分享,去创建一个
P. Garcı́a-Gutiérrez | A. Landa-Piedra | A. Rodrı́guez-Romero | R. Parra-Unda | A. Rojo-Domı́nguez | A. Rodríguez‐Romero | P. García-Gutiérrez | R. Parra-Unda | A. Rojo-Domínguez | A. Landa-Piedra
[1] G. Román,et al. Neurocysticercosis : a clinical handbook , 1998 .
[2] W. Hauser,et al. Cysticercosis and Epilepsy: A Critical Review , 1998, Epilepsia.
[3] I. Duce,et al. Natural plant cysteine proteinases as anthelmintics? , 2004, Trends in parasitology.
[4] A. Rosato,et al. Backbone dynamics of human Cu,Zn superoxide dismutase and of its monomeric F50E/G51E/E133Q mutant: the influence of dimerization on mobility and function. , 2000, Biochemistry.
[5] The solution structure of a monomeric, reduced form of human copper,zinc superoxide dismutase bearing the same charge as the native protein , 1999, JBIC Journal of Biological Inorganic Chemistry.
[6] S. Wilkinson,et al. Overexpression of superoxide dismutase in Trypanosoma cruzi results in increased sensitivity to the trypanocidal agents gentian violet and benznidazole. , 1998, Molecular and biochemical parasitology.
[7] P. Köhler,et al. The biochemical basis of anthelmintic action and resistance. , 2001, International journal for parasitology.
[8] S. Gunn. FACTS AND PRINCIPLES. , 1911, Science.
[9] Marco Di Benedetto,et al. Solution structure of reduced monomeric Q133M2 copper, zinc superoxide dismutase (SOD). Why is SOD a dimeric enzyme?. , 1998, Biochemistry.
[10] P. LoVerde. Do antioxidants play a role in schistosome host-parasite interactions? , 1998, Parasitology today.
[11] M. Wallin,et al. Neurocysticercosis in the United States , 2004, Neurology.
[12] I. Fridovich,et al. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). , 1969, The Journal of biological chemistry.
[13] F. Vaca-Paniagua,et al. Taenia solium: antioxidant metabolism enzymes as targets for cestocidal drugs and vaccines. , 2008, Current topics in medicinal chemistry.
[14] W. Cheng-I. Parasitic diarrhoeas in China. , 1988, Parasitology today.
[15] J. Serpa,et al. Neurocysticercosis in the United States , 2012, Pathogens and global health.
[16] H. Birnboim,et al. The production of DNA strand breaks in human leukocytes by superoxide anion may involve a metabolic process. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[17] C. Evans,et al. Magnitude of the disease burden from neurocysticercosis in a developing country. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] O. Takayanagui,et al. Therapy for neurocysticercosis. Comparison between albendazole and praziquantel. , 1992, Archives of neurology.
[19] P. Charifson,et al. Conformational analysis of drug-like molecules bound to proteins: an extensive study of ligand reorganization upon binding. , 2004, Journal of medicinal chemistry.
[20] M. Sánchez-Moreno,et al. Superoxide dismutase in cestodes. Isoenzymatic characterization and studies of inhibition by a series of benzimidazoles and by pyrimidine derivatives of recent synthesis. , 1987, Arzneimittel-Forschung.
[21] R. Krecek,et al. The current status of neurocysticercosis in Eastern and Southern Africa. , 2003, Acta tropica.
[22] C. Evans,et al. Taenia solium cysticercosis , 2003, The Lancet.
[23] A. Castellanos-Gonzalez,et al. Cloning, production and characterisation of a recombinant Cu/Zn superoxide dismutase from Taenia solium. , 2002, International journal for parasitology.
[24] I. Kuntz. Structure-Based Strategies for Drug Design and Discovery , 1992, Science.
[25] Herbert Edelsbrunner,et al. Weighted alpha shapes , 1992 .
[26] B. Luty,et al. Simulation of the bimolecular reaction between superoxide and superoxide dismutase : synthesis of the encounter and reaction steps , 1993 .
[27] Min-Sun Park,et al. Evaluating Docking Methods for Prediction of Binding Affinities of Small Molecules to the G Protein βγ Subunits , 2009, J. Chem. Inf. Model..
[28] M. Ferraroni,et al. The crystal structure of the monomeric human SOD mutant F50E/G51E/E133Q at atomic resolution. The enzyme mechanism revisited. , 1999, Journal of molecular biology.
[29] H. Edelsbrunner,et al. Anatomy of protein pockets and cavities: Measurement of binding site geometry and implications for ligand design , 1998, Protein science : a publication of the Protein Society.
[30] A. Rodríguez‐Romero,et al. Crystal structure of Cu / Zn superoxide dismutase from Taenia solium reveals metal‐mediated self‐assembly , 2011, The FEBS journal.
[31] Maria Paola Costi,et al. Homodimeric enzymes as drug targets. , 2010, Current medicinal chemistry.
[32] M. J. Yunta,et al. Efficient inhibition of iron superoxide dismutase and of Trypanosoma cruzi growth by benzo[g]phthalazine derivatives functionalized with one or two imidazole rings. , 2008, Journal of medicinal chemistry.
[33] Alasdair T. R. Laurie,et al. Methods for the prediction of protein-ligand binding sites for structure-based drug design and virtual ligand screening. , 2006, Current protein & peptide science.
[34] M F Sanner,et al. Python: a programming language for software integration and development. , 1999, Journal of molecular graphics & modelling.
[35] I. Fridovich,et al. Oxygen toxicity: a radical explanation. , 1998, The Journal of experimental biology.
[36] Krystal J Alligood,et al. A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib) , 2004, Cancer Research.
[37] K. Henkle-Dührsen,et al. Antioxidant enzyme families in parasitic nematodes. , 2001, Molecular and biochemical parasitology.
[38] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..